Levocetirizina Ciclum

Levocetirizine, the active ingredient in Levocetirizina Ciclum, is a H1 receptor antagonist presented as an oral tablet for oral use. It is employed to relieve symptoms of allergic rhinitis and chronic idiopathic urticaria in adults and adolescents.

GNH USA supplies Levocetirizina Ciclum as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support import and distribution. Its global network ensures reliable logistics and timely delivery across multiple regions, meeting the needs of healthcare providers.

Levocetirizine is an antihistamine that targets H1‑mediated allergic pathways, providing relief in several allergic conditions.

Allergic rhinitis: reduces nasal congestion, sneezing, and itching associated with seasonal or perennial allergens. Chronic idiopathic urticaria: alleviates hives and associated itching that persist without an identifiable trigger. Allergic conjunctivitis: diminishes eye redness, tearing, and itching caused by allergen exposure.

Levocetirizine may cause adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Drowsiness: mild sedation or sleepiness, especially at treatment initiation. - Dry mouth: reduced salivation leading to throat discomfort. - Headache: transient cranial pain of varying intensity. - Nausea: mild gastrointestinal upset.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips, tongue, or airway requiring urgent care. - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Anaphylaxis: rapid onset systemic allergic reaction that can be life‑threatening. - Thrombocytopenia: marked reduction in platelet count, increasing bleeding risk. - Hepatic dysfunction: elevated liver enzymes indicating possible liver injury.

Before prescribing Levocetirizine, clinicians should consider several precautionary measures to ensure safe use. - Renal function assessment: dose adjustment may be required in severe renal impairment. - Hepatic disease caution: use carefully in patients with liver dysfunction. - Sedation monitoring: advise patients not to operate machinery if drowsy. - Allergy history review: avoid in individuals with known hypersensitivity to levocetirizine. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Levocetirizine can interact with other medicines, influencing its efficacy or safety profile.

Major Interactions (Avoid): - Alcohol: may potentiate sedative effects, increasing drowsiness. - Central nervous system depressants (e.g., benzodiazepines): additive sedation risk.

Moderate Interactions (Monitor Closely): - Ketoconazole or other strong CYP3A4 inhibitors: may raise levocetirizine plasma concentrations. - Ritonavir: can increase drug levels, requiring clinical observation. - Theophylline: levocetirizine may reduce theophylline clearance, potentially altering its effect.